Alendronic Acid Produces Greater Effects than Risedronic Acid on Bone Density and Turnover in Postmenopausal Women with Osteoporosis: Results of FACTS1 1 Fosamax Actonel Comparison Trials. -International

By Reid David M.  

Clinical Drug Investigation, Vol. 26, Iss. 2, 2006-01 ,pp. : 63-74

Adis International

Access to resources Recommend Favorite

Zoledronic acid: an advance in tumour bone disease therapy and a new hope for osteoporosis

By Body Jean-Jacques  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 4, 2003-04 ,pp. : 567-580

Informa Healthcare

Access to resources Recommend Favorite

Zoledronic acid for prevention and treatment of osteoporosis

By Recknor Chris  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 5, 2011-04 ,pp. : 807-815

Informa Healthcare

Access to resources Recommend Favorite

5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial

By Wagner-Johnston Nina D.   Sloan Jeff A.   Liu Heshan   Kearns Ann E.   Hines Stephanie L.   Puttabasavaiah Suneetha   Dakhil Shaker R.   Lafky Jacqueline M.   Perez Edith A.   Loprinzi Charles L.  

Cancer, Vol. 121, Iss. 15, 2015-08 ,pp. : 2537-2543

Blackwell Publishing

Access to resources Recommend Favorite

Zoledronic acid reduces fracture risk . . .

By  

Inpharma, Vol. 1, Iss. 1587, 2007-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite